Financial results - ATLASPHARM S.R.L.

Financial Summary - Atlaspharm S.r.l.
Unique identification code: 16650840
Registration number: J40/12576/2004
Nace: 7112
Sales - Ron
53.092
Net Profit - Ron
21.965
Employees
Open Account
Company Atlaspharm S.r.l. with Fiscal Code 16650840 recorded a turnover of 2025 of 53.092, with a net profit of 21.965 and having an average number of employees of - . The company operates in the field of Activităţi de inginerie şi consultanţă tehnică legate de acestea having the NACE code 7112.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Atlaspharm S.r.l.

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Sales - EUR 42.031 41.992 41.846 91.718 96.010 120.991 121.777 160.090 235.807 53.092
Total Income - EUR 42.104 42.073 41.965 91.856 96.105 121.410 121.911 160.380 238.804 58.028
Total Expenses - EUR 17.331 24.677 24.331 39.635 16.210 26.192 36.601 25.681 34.418 29.510
Gross Profit/Loss - EUR 24.774 17.395 17.634 52.221 79.895 95.219 85.310 134.698 204.386 28.518
Net Profit/Loss - EUR 20.453 13.922 17.215 51.303 78.829 94.047 84.293 112.108 169.409 21.965
Employees 1 1 1 1 1 1 1 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -77.2%, from 235.807 euro in the year 2024, to 53.092 euro in 2025. The Net Profit decreased by -145.186 euro, from 169.409 euro in 2024, to 21.965 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Atlaspharm S.r.l.

Rating financiar

Financial Rating -
ATLASPHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Atlaspharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Atlaspharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Atlaspharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Atlaspharm S.r.l. - CUI 16650840

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Fixed Assets 72.205 71.533 71.004 85.907 79.030 70.798 65.230 64.108 63.776 67.263
Current Assets 36.393 13.347 31.265 25.642 76.251 135.795 168.079 241.117 317.262 259.823
Inventories 916 1.692 21.382 0 0 0 0 0 902 0
Receivables 0 0 0 47 70 894 515 3.983 610 471
Cash 35.477 11.655 9.884 25.595 76.181 134.901 167.563 237.134 315.750 259.352
Shareholders Funds 50.012 63.088 79.145 100.992 129.209 200.176 187.650 248.648 292.551 162.954
Social Capital 45 44 43 42 41 40 41 40 40 40
Debts 58.586 21.792 23.124 10.556 26.072 7.423 45.659 56.643 88.487 164.132
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 5.0415 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908
Main CAEN "7112 - 7112"
CAEN Financial Year 7112
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 259.823 euro in 2025 which includes Inventories of 0 euro, Receivables of 471 euro and cash availability of 259.352 euro.
The company's Equity was valued at 162.954 euro, while total Liabilities amounted to 164.132 euro. Equity decreased by -125.698 euro, from 292.551 euro in 2024, to 162.954 in 2025.

Risk Reports Prices

Reviews - Atlaspharm S.r.l.

Comments - Atlaspharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.